(Stroke. 2000;31:940.)
© 2000 American Heart Association, Inc.
Original Contributions |
Postischemic Attenuation of Cerebral Artery Reactivity Is Increased in the Presence of Tissue Plasminogen Activator
From the Departments of Obstetrics/Gynecology, Pharmacology, and Neurology, University of Vermont College of Medicine, Burlington, Vt (M.J.C.); and the Oregon Stroke Center, Oregon Health Sciences University, Portland, Ore (N.L., W.M.C.).
Correspondence and reprint requests to Marilyn J. Cipolla, PhD, Departments of Obstetrics/Gynecology, Pharmacology, and Neurology, Given Building, Room C256, Burlington, VT 05405. E-mail: mcipolla{at}zoo.uvm.edu
Background and Purpose—We investigated the combined effect of tissue plasminogen activator and ischemia on middle cerebral artery (MCA) reactivity to determine whether abnormal MCA function after 2 hours of ischemia was worse in arteries perfused with recombinant tissue plasminogen activator (rtPA).
Methods—The intraluminal suture model of focal cerebral ischemia was used to induce 2 hours of ischemia in rats, after which occluded MCAs were removed and studied in vitro with an arteriograph system that allowed control of transmural pressure (TMP) and measurement of lumen diameter. Arteries were either nonischemic (control; n=8), nonischemic and perfused with 400 µg/mL rtPA (rtPA; n=5), ischemic (ISC; n=6), or ischemic and perfused with 400 µg/mL rtPA (ISC-rtPA; n=6). After a 1-hour equilibration at 75 mm Hg, TMP was increased to 125 mm Hg and lumen diameter was recorded at each pressure. Reactivity to acetylcholine (ACh, 0.1 to 10.0 µmol/L) and serotonin (0.01 to 10 µmol/L) was then determined.
Results—Control arteries responded myogenically to pressure and increased the amount of tone from 18.5±3.8% at 75 mm Hg to 24.8±3.0% at 125 mm Hg (P<0.05), which decreased diameter from 241±7 to 232±6 µm. In contrast, all other groups decreased tone at 125 mm Hg, which demonstrated a loss of myogenicity. The percent tone in each group at 75 versus 125 mm Hg was rtPA, 16.0±4.5% versus 11.8±3.8%; ISC, 23.5±4.5% versus 13.5±3.1%; and ISC-rtPA, 23.5±4.2% versus 12.3±3.2% (P<0.05 for all). The percent increase in lumen diameter at each concentration of ACh was diminished in all groups compared with control; ISC-rtPA arteries responded the least, which suggests an additive effect of rtPA in ischemic arteries. The percent increase in lumen diameter at 10-5mol/L ACh was 23±4% for control versus 15±2% for rtPA; 17±3% for ISC arteries (P<0.05), and 8±2% for ISC-rtPA arteries (P<0.01). Sensitivity to serotonin was equally diminished in all groups compared with control: EC50 (µmol/L) was 0.06±0.01 for control, 0.17±0.02 for rtPA, 0.22±0.07 for ISC, and 0.16±0.04 for ISC-rtPA (P<0.05).
Conclusions—These results demonstrate that both ischemia and rtPA perfusion diminish cerebral artery reactivity and that the combination may produce an additive effect. This impaired reactivity may contribute to reperfusion-induced injury during or after thrombolysis by altering upstream cerebrovascular resistance.
Editorial Comment
Department of Neurology, University of Virginia Health System, Charlottesville, Virginia
This article has been cited by other articles:
 |
|
 |
|
  M.-K. Sun, J. Hongpaisan, T. J. Nelson, and D. L. Alkon Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains PNAS, September 9, 2008; 105(36): 13620 - 13625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Park, E. F. Gallo, J. Anrather, G. Wang, E. H. Norris, J. Paul, S. Strickland, and C. Iadecola Key role of tissue plasminogen activator in neurovascular coupling PNAS, January 22, 2008; 105(3): 1073 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Rigsby, A. E. Burch, S. Ogbi, D. M. Pollock, and A. M. Dorrance Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1754 - R1763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Schaefer, T. Machida, S. Vorlova, S. Strickland, and R. Levi The plasminogen activator system modulates sympathetic nerve function J. Exp. Med., September 4, 2006; 203(9): 2191 - 2200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Maneen, R. Hannah, L. Vitullo, N. DeLance, and M. J. Cipolla Peroxynitrite Diminishes Myogenic Activity and Is Associated With Decreased Vascular Smooth Muscle F-Actin in Rat Posterior Cerebral Arteries Stroke, March 1, 2006; 37(3): 894 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Fagan, D. C. Hess, E. J. Hohnadel, D. M. Pollock, and A. Ergul Targets for Vascular Protection After Acute Ischemic Stroke Stroke, September 1, 2004; 35(9): 2220 - 2225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nassar, S.'e. Akkawi, A. Shina, A. Haj-Yehia, K. Bdeir, M. Tarshis, S. N. Heyman, and A. A.-R. Higazi In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone Blood, February 1, 2004; 103(3): 897 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gautier, O. Petrault, P. Gele, M. Laprais, M. Bastide, A. Bauters, D. Deplanque, B. Jude, J. Caron, and R. Bordet Involvement of Thrombolysis in Recombinant Tissue Plasminogen Activator-Induced Cerebral Hemorrhages and Effect on Infarct Volume and Postischemic Endothelial Function Stroke, December 1, 2003; 34(12): 2975 - 2979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cambj-Sapunar, M. Yu, D. R. Harder, and R. J. Roman Contribution of 5-Hydroxytryptamine1B Receptors and 20-Hydroxyeiscosatetraenoic Acid to Fall in Cerebral Blood Flow After Subarachnoid Hemorrhage Stroke, May 1, 2003; 34(5): 1269 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Madden, W. Clark, and N. Lessov Failure of Ischemic Neuroprotection by Potentiators of Gamma-aminobutyric Acid Clin. Med. Res., April 1, 2003; 1(2): 119 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Cipolla and A. B. Curry Middle Cerebral Artery Function After Stroke: The Threshold Duration of Reperfusion for Myogenic Activity Stroke, August 1, 2002; 33(8): 2094 - 2099. [Abstract] [Full Text] [PDF]
|
|